329 related articles for article (PubMed ID: 18591458)
21. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
22. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL
Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645
[TBL] [Abstract][Full Text] [Related]
23. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
[TBL] [Abstract][Full Text] [Related]
25. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
[TBL] [Abstract][Full Text] [Related]
26. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
[TBL] [Abstract][Full Text] [Related]
27. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
[TBL] [Abstract][Full Text] [Related]
28. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder.
Matsui H; Ando K; Kawarazaki H; Nagae A; Fujita M; Shimosawa T; Nagase M; Fujita T
Hypertension; 2008 Aug; 52(2):287-94. PubMed ID: 18606904
[TBL] [Abstract][Full Text] [Related]
29. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.
Hattori T; Murase T; Iwase E; Takahashi K; Ohtake M; Tsuboi K; Ohtake M; Miyachi M; Murohara T; Nagata K
Nagoya J Med Sci; 2013 Feb; 75(1-2):81-92. PubMed ID: 23544271
[TBL] [Abstract][Full Text] [Related]
31. Effects of spironolactone on systolic blood pressure in experimental diabetic rats.
Liu YJ; Nakagawa Y; Toya K; Wang Y; Saegusa H; Nakanishi T; Ohzeki T
Kidney Int; 2000 May; 57(5):2064-71. PubMed ID: 10792625
[TBL] [Abstract][Full Text] [Related]
32. Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
Kawarazaki H; Ando K; Shibata S; Muraoka K; Fujita M; Kawarasaki C; Fujita T
J Hypertens; 2012 Oct; 30(10):1977-85. PubMed ID: 22914542
[TBL] [Abstract][Full Text] [Related]
33. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR
World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400
[TBL] [Abstract][Full Text] [Related]
34. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
[TBL] [Abstract][Full Text] [Related]
35. Effect of spironolactone on hypertrophy of left ventricular myocardium in wistar rats with experimental uremia.
Karabayeva AZh; Esaian AM; Kayukov IG; Parastaeva MM; Beresneva ON; Kotenko LV; Sevastyanova IE
Bull Exp Biol Med; 2008 Jun; 145(6):714-6. PubMed ID: 19110558
[TBL] [Abstract][Full Text] [Related]
36. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
[TBL] [Abstract][Full Text] [Related]
37. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
[TBL] [Abstract][Full Text] [Related]
38. Early aldosterone up-regulated genes: new pathways for renal disease?
Kellner M; Peiter A; Hafner M; Feuring M; Christ M; Wehling M; Falkenstein E; Lösel R
Kidney Int; 2003 Oct; 64(4):1199-207. PubMed ID: 12969137
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
Luther JM; Gainer JV; Murphey LJ; Yu C; Vaughan DE; Morrow JD; Brown NJ
Hypertension; 2006 Dec; 48(6):1050-7. PubMed ID: 17043157
[TBL] [Abstract][Full Text] [Related]
40. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V
J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]